世界のIVD感染症市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global IVD Infectious Disease Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z3295 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、IVD感染症のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（生化学的診断、免疫診断、分子診断、微生物学的診断、尿診断、凝固診断、その他）、用途別市場規模（個人用、商業用、学術、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・IVD感染症の市場動向 ・企業の競争状況、市場シェア ・IVD感染症の種類別市場規模（生化学的診断、免疫診断、分子診断、微生物学的診断、尿診断、凝固診断、その他） ・IVD感染症の用途別市場規模（個人用、商業用、学術、その他） ・IVD感染症の北米市場規模2016-2027（アメリカ、カナダ） ・IVD感染症のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・IVD感染症のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・IVD感染症の中南米市場規模2016-2027（メキシコ、ブラジル） ・IVD感染症の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Roche Diagnostics、Abbott Laboratories、Abbott、Gen-Probe、Becton Dickinson (BD)、Bio-Rad Laboratories、Siemens Healthcare、Biomérieux、Danaher、Thermo Fisher、Sysmex） ・結論

In Vitro Diagnosis, or IVD (In Vitro Diagnosis), refers to the product and service of disease or body function that is obtained by testing human samples (blood, body fluids, tissues, etc.).
Geographically, North America is the world’s largest extracorporeal diagnostic market. Europe and the United States together account for more than 65 percent of the global market. Japan has the largest share of the Asian in vitro diagnosis market, with an 8.73% market share.

Market Analysis and Insights: Global IVD Infectious Disease Market
The global IVD Infectious Disease market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global IVD Infectious Disease market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global IVD Infectious Disease market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global IVD Infectious Disease market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global IVD Infectious Disease market.

Global IVD Infectious Disease Scope and Market Size
IVD Infectious Disease market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global IVD Infectious Disease market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Biochemical Diagnosis
Immune Diagnosis
Molecular Diagnosis
Microbiological Diagnosis
Urine Diagnosis
Coagulation Diagnosis
Other

Segment by Application
Personal
Commercial
Academic
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Roche Diagnostics
Abbott Laboratories
Abbott
Gen-Probe
Becton Dickinson (BD)
Bio-Rad Laboratories
Siemens Healthcare
Biomérieux
Danaher

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global IVD Infectious Disease Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Biochemical Diagnosis
1.2.3 Immune Diagnosis
1.2.4 Molecular Diagnosis
1.2.5 Microbiological Diagnosis
1.2.6 Urine Diagnosis
1.2.7 Coagulation Diagnosis
1.2.8 Other
1.3 Market by Application
1.3.1 Global IVD Infectious Disease Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Personal
1.3.3 Commercial
1.3.4 Academic
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global IVD Infectious Disease Market Perspective (2016-2027)
2.2 IVD Infectious Disease Growth Trends by Regions
2.2.1 IVD Infectious Disease Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 IVD Infectious Disease Historic Market Share by Regions (2016-2021)
2.2.3 IVD Infectious Disease Forecasted Market Size by Regions (2022-2027)
2.3 IVD Infectious Disease Industry Dynamic
2.3.1 IVD Infectious Disease Market Trends
2.3.2 IVD Infectious Disease Market Drivers
2.3.3 IVD Infectious Disease Market Challenges
2.3.4 IVD Infectious Disease Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top IVD Infectious Disease Players by Revenue
3.1.1 Global Top IVD Infectious Disease Players by Revenue (2016-2021)
3.1.2 Global IVD Infectious Disease Revenue Market Share by Players (2016-2021)
3.2 Global IVD Infectious Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by IVD Infectious Disease Revenue
3.4 Global IVD Infectious Disease Market Concentration Ratio
3.4.1 Global IVD Infectious Disease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by IVD Infectious Disease Revenue in 2020
3.5 IVD Infectious Disease Key Players Head office and Area Served
3.6 Key Players IVD Infectious Disease Product Solution and Service
3.7 Date of Enter into IVD Infectious Disease Market
3.8 Mergers & Acquisitions, Expansion Plans

4 IVD Infectious Disease Breakdown Data by Type
4.1 Global IVD Infectious Disease Historic Market Size by Type (2016-2021)
4.2 Global IVD Infectious Disease Forecasted Market Size by Type (2022-2027)

5 IVD Infectious Disease Breakdown Data by Application
5.1 Global IVD Infectious Disease Historic Market Size by Application (2016-2021)
5.2 Global IVD Infectious Disease Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America IVD Infectious Disease Market Size (2016-2027)
6.2 North America IVD Infectious Disease Market Size by Type
6.2.1 North America IVD Infectious Disease Market Size by Type (2016-2021)
6.2.2 North America IVD Infectious Disease Market Size by Type (2022-2027)
6.2.3 North America IVD Infectious Disease Market Size by Type (2016-2027)
6.3 North America IVD Infectious Disease Market Size by Application
6.3.1 North America IVD Infectious Disease Market Size by Application (2016-2021)
6.3.2 North America IVD Infectious Disease Market Size by Application (2022-2027)
6.3.3 North America IVD Infectious Disease Market Size by Application (2016-2027)
6.4 North America IVD Infectious Disease Market Size by Country
6.4.1 North America IVD Infectious Disease Market Size by Country (2016-2021)
6.4.2 North America IVD Infectious Disease Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe IVD Infectious Disease Market Size (2016-2027)
7.2 Europe IVD Infectious Disease Market Size by Type
7.2.1 Europe IVD Infectious Disease Market Size by Type (2016-2021)
7.2.2 Europe IVD Infectious Disease Market Size by Type (2022-2027)
7.2.3 Europe IVD Infectious Disease Market Size by Type (2016-2027)
7.3 Europe IVD Infectious Disease Market Size by Application
7.3.1 Europe IVD Infectious Disease Market Size by Application (2016-2021)
7.3.2 Europe IVD Infectious Disease Market Size by Application (2022-2027)
7.3.3 Europe IVD Infectious Disease Market Size by Application (2016-2027)
7.4 Europe IVD Infectious Disease Market Size by Country
7.4.1 Europe IVD Infectious Disease Market Size by Country (2016-2021)
7.4.2 Europe IVD Infectious Disease Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific IVD Infectious Disease Market Size (2016-2027)
8.2 Asia-Pacific IVD Infectious Disease Market Size by Type
8.2.1 Asia-Pacific IVD Infectious Disease Market Size by Type (2016-2021)
8.2.2 Asia-Pacific IVD Infectious Disease Market Size by Type (2022-2027)
8.2.3 Asia-Pacific IVD Infectious Disease Market Size by Type (2016-2027)
8.3 Asia-Pacific IVD Infectious Disease Market Size by Application
8.3.1 Asia-Pacific IVD Infectious Disease Market Size by Application (2016-2021)
8.3.2 Asia-Pacific IVD Infectious Disease Market Size by Application (2022-2027)
8.3.3 Asia-Pacific IVD Infectious Disease Market Size by Application (2016-2027)
8.4 Asia-Pacific IVD Infectious Disease Market Size by Region
8.4.1 Asia-Pacific IVD Infectious Disease Market Size by Region (2016-2021)
8.4.2 Asia-Pacific IVD Infectious Disease Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America IVD Infectious Disease Market Size (2016-2027)
9.2 Latin America IVD Infectious Disease Market Size by Type
9.2.1 Latin America IVD Infectious Disease Market Size by Type (2016-2021)
9.2.2 Latin America IVD Infectious Disease Market Size by Type (2022-2027)
9.2.3 Latin America IVD Infectious Disease Market Size by Type (2016-2027)
9.3 Latin America IVD Infectious Disease Market Size by Application
9.3.1 Latin America IVD Infectious Disease Market Size by Application (2016-2021)
9.3.2 Latin America IVD Infectious Disease Market Size by Application (2022-2027)
9.3.3 Latin America IVD Infectious Disease Market Size by Application (2016-2027)
9.4 Latin America IVD Infectious Disease Market Size by Country
9.4.1 Latin America IVD Infectious Disease Market Size by Country (2016-2021)
9.4.2 Latin America IVD Infectious Disease Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa IVD Infectious Disease Market Size (2016-2027)
10.2 Middle East & Africa IVD Infectious Disease Market Size by Type
10.2.1 Middle East & Africa IVD Infectious Disease Market Size by Type (2016-2021)
10.2.2 Middle East & Africa IVD Infectious Disease Market Size by Type (2022-2027)
10.2.3 Middle East & Africa IVD Infectious Disease Market Size by Type (2016-2027)
10.3 Middle East & Africa IVD Infectious Disease Market Size by Application
10.3.1 Middle East & Africa IVD Infectious Disease Market Size by Application (2016-2021)
10.3.2 Middle East & Africa IVD Infectious Disease Market Size by Application (2022-2027)
10.3.3 Middle East & Africa IVD Infectious Disease Market Size by Application (2016-2027)
10.4 Middle East & Africa IVD Infectious Disease Market Size by Country
10.4.1 Middle East & Africa IVD Infectious Disease Market Size by Country (2016-2021)
10.4.2 Middle East & Africa IVD Infectious Disease Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Roche Diagnostics
11.1.1 Roche Diagnostics Company Details
11.1.2 Roche Diagnostics Business Overview
11.1.3 Roche Diagnostics IVD Infectious Disease Introduction
11.1.4 Roche Diagnostics Revenue in IVD Infectious Disease Business (2016-2021)
11.1.5 Roche Diagnostics Recent Development
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Details
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories IVD Infectious Disease Introduction
11.2.4 Abbott Laboratories Revenue in IVD Infectious Disease Business (2016-2021)
11.2.5 Abbott Laboratories Recent Development
11.3 Abbott
11.3.1 Abbott Company Details
11.3.2 Abbott Business Overview
11.3.3 Abbott IVD Infectious Disease Introduction
11.3.4 Abbott Revenue in IVD Infectious Disease Business (2016-2021)
11.3.5 Abbott Recent Development
11.4 Gen-Probe
11.4.1 Gen-Probe Company Details
11.4.2 Gen-Probe Business Overview
11.4.3 Gen-Probe IVD Infectious Disease Introduction
11.4.4 Gen-Probe Revenue in IVD Infectious Disease Business (2016-2021)
11.4.5 Gen-Probe Recent Development
11.5 Becton Dickinson (BD)
11.5.1 Becton Dickinson (BD) Company Details
11.5.2 Becton Dickinson (BD) Business Overview
11.5.3 Becton Dickinson (BD) IVD Infectious Disease Introduction
11.5.4 Becton Dickinson (BD) Revenue in IVD Infectious Disease Business (2016-2021)
11.5.5 Becton Dickinson (BD) Recent Development
11.6 Bio-Rad Laboratories
11.6.1 Bio-Rad Laboratories Company Details
11.6.2 Bio-Rad Laboratories Business Overview
11.6.3 Bio-Rad Laboratories IVD Infectious Disease Introduction
11.6.4 Bio-Rad Laboratories Revenue in IVD Infectious Disease Business (2016-2021)
11.6.5 Bio-Rad Laboratories Recent Development
11.7 Siemens Healthcare
11.7.1 Siemens Healthcare Company Details
11.7.2 Siemens Healthcare Business Overview
11.7.3 Siemens Healthcare IVD Infectious Disease Introduction
11.7.4 Siemens Healthcare Revenue in IVD Infectious Disease Business (2016-2021)
11.7.5 Siemens Healthcare Recent Development
11.8 Biomérieux
11.8.1 Biomérieux Company Details
11.8.2 Biomérieux Business Overview
11.8.3 Biomérieux IVD Infectious Disease Introduction
11.8.4 Biomérieux Revenue in IVD Infectious Disease Business (2016-2021)
11.8.5 Biomérieux Recent Development
11.9 Danaher
11.9.1 Danaher Company Details
11.9.2 Danaher Business Overview
11.9.3 Danaher IVD Infectious Disease Introduction
11.9.4 Danaher Revenue in IVD Infectious Disease Business (2016-2021)
11.9.5 Danaher Recent Development
11.10 Thermo Fisher
11.10.1 Thermo Fisher Company Details
11.10.2 Thermo Fisher Business Overview
11.10.3 Thermo Fisher IVD Infectious Disease Introduction
11.10.4 Thermo Fisher Revenue in IVD Infectious Disease Business (2016-2021)
11.10.5 Thermo Fisher Recent Development
11.11 Sysmex
11.11.1 Sysmex Company Details
11.11.2 Sysmex Business Overview
11.11.3 Sysmex IVD Infectious Disease Introduction
11.11.4 Sysmex Revenue in IVD Infectious Disease Business (2016-2021)
11.11.5 Sysmex Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global IVD Infectious Disease Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Biochemical Diagnosis
Table 3. Key Players of Immune Diagnosis
Table 4. Key Players of Molecular Diagnosis
Table 5. Key Players of Microbiological Diagnosis
Table 6. Key Players of Urine Diagnosis
Table 7. Key Players of Coagulation Diagnosis
Table 8. Key Players of Other
Table 9. Global IVD Infectious Disease Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global IVD Infectious Disease Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global IVD Infectious Disease Market Size by Regions (2016-2021) & (US$ Million)
Table 12. Global IVD Infectious Disease Market Share by Regions (2016-2021)
Table 13. Global IVD Infectious Disease Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 14. Global IVD Infectious Disease Market Share by Regions (2022-2027)
Table 15. IVD Infectious Disease Market Trends
Table 16. IVD Infectious Disease Market Drivers
Table 17. IVD Infectious Disease Market Challenges
Table 18. IVD Infectious Disease Market Restraints
Table 19. Global IVD Infectious Disease Revenue by Players (2016-2021) & (US$ Million)
Table 20. Global IVD Infectious Disease Market Share by Players (2016-2021)
Table 21. Global Top IVD Infectious Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in IVD Infectious Disease as of 2020)
Table 22. Ranking of Global Top IVD Infectious Disease Companies by Revenue (US$ Million) in 2020
Table 23. Global 5 Largest Players Market Share by IVD Infectious Disease Revenue (CR5 and HHI) & (2016-2021)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players IVD Infectious Disease Product Solution and Service
Table 26. Date of Enter into IVD Infectious Disease Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global IVD Infectious Disease Market Size by Type (2016-2021) (US$ Million)
Table 29. Global IVD Infectious Disease Revenue Market Share by Type (2016-2021)
Table 30. Global IVD Infectious Disease Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 31. Global IVD Infectious Disease Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 32. Global IVD Infectious Disease Market Size Share by Application (2016-2021) & (US$ Million)
Table 33. Global IVD Infectious Disease Revenue Market Share by Application (2016-2021)
Table 34. Global IVD Infectious Disease Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 35. Global IVD Infectious Disease Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 36. North America IVD Infectious Disease Market Size by Type (2016-2021) (US$ Million)
Table 37. North America IVD Infectious Disease Market Size by Type (2022-2027) & (US$ Million)
Table 38. North America IVD Infectious Disease Market Size by Application (2016-2021) (US$ Million)
Table 39. North America IVD Infectious Disease Market Size by Application (2022-2027) & (US$ Million)
Table 40. North America IVD Infectious Disease Market Size by Country (2016-2021) & (US$ Million)
Table 41. North America IVD Infectious Disease Market Size by Country (2022-2027) & (US$ Million)
Table 42. Europe IVD Infectious Disease Market Size by Type (2016-2021) (US$ Million)
Table 43. Europe IVD Infectious Disease Market Size by Type (2022-2027) & (US$ Million)
Table 44. Europe IVD Infectious Disease Market Size by Application (2016-2021) (US$ Million)
Table 45. Europe IVD Infectious Disease Market Size by Application (2022-2027) & (US$ Million)
Table 46. Europe IVD Infectious Disease Market Size by Country (2016-2021) & (US$ Million)
Table 47. Europe IVD Infectious Disease Market Size by Country (2022-2027) & (US$ Million)
Table 48. Asia-Pacific IVD Infectious Disease Market Size by Type (2016-2021) (US$ Million)
Table 49. Asia-Pacific IVD Infectious Disease Market Size by Type (2022-2027) & (US$ Million)
Table 50. Asia-Pacific IVD Infectious Disease Market Size by Application (2016-2021) (US$ Million)
Table 51. Asia-Pacific IVD Infectious Disease Market Size by Application (2022-2027) & (US$ Million)
Table 52. Asia-Pacific IVD Infectious Disease Market Size by Region (2016-2021) & (US$ Million)
Table 53. Asia-Pacific IVD Infectious Disease Market Size by Region (2022-2027) & (US$ Million)
Table 54. Latin America IVD Infectious Disease Market Size by Type (2016-2021) (US$ Million)
Table 55. Latin America IVD Infectious Disease Market Size by Type (2022-2027) & (US$ Million)
Table 56. Latin America IVD Infectious Disease Market Size by Application (2016-2021) (US$ Million)
Table 57. Latin America IVD Infectious Disease Market Size by Application (2022-2027) & (US$ Million)
Table 58. Latin America IVD Infectious Disease Market Size by Country (2016-2021) & (US$ Million)
Table 59. Latin America IVD Infectious Disease Market Size by Country (2022-2027) & (US$ Million)
Table 60. Middle East & Africa IVD Infectious Disease Market Size by Type (2016-2021) (US$ Million)
Table 61. Middle East & Africa IVD Infectious Disease Market Size by Type (2022-2027) & (US$ Million)
Table 62. Middle East & Africa IVD Infectious Disease Market Size by Application (2016-2021) (US$ Million)
Table 63. Middle East & Africa IVD Infectious Disease Market Size by Application (2022-2027) & (US$ Million)
Table 64. Middle East & Africa IVD Infectious Disease Market Size by Country (2016-2021) & (US$ Million)
Table 65. Middle East & Africa IVD Infectious Disease Market Size by Country (2022-2027) & (US$ Million)
Table 66. Roche Diagnostics Company Details
Table 67. Roche Diagnostics Business Overview
Table 68. Roche Diagnostics IVD Infectious Disease Product
Table 69. Roche Diagnostics Revenue in IVD Infectious Disease Business (2016-2021) & (US$ Million)
Table 70. Roche Diagnostics Recent Development
Table 71. Abbott Laboratories Company Details
Table 72. Abbott Laboratories Business Overview
Table 73. Abbott Laboratories IVD Infectious Disease Product
Table 74. Abbott Laboratories Revenue in IVD Infectious Disease Business (2016-2021) & (US$ Million)
Table 75. Abbott Laboratories Recent Development
Table 76. Abbott Company Details
Table 77. Abbott Business Overview
Table 78. Abbott IVD Infectious Disease Product
Table 79. Abbott Revenue in IVD Infectious Disease Business (2016-2021) & (US$ Million)
Table 80. Abbott Recent Development
Table 81. Gen-Probe Company Details
Table 82. Gen-Probe Business Overview
Table 83. Gen-Probe IVD Infectious Disease Product
Table 84. Gen-Probe Revenue in IVD Infectious Disease Business (2016-2021) & (US$ Million)
Table 85. Gen-Probe Recent Development
Table 86. Becton Dickinson (BD) Company Details
Table 87. Becton Dickinson (BD) Business Overview
Table 88. Becton Dickinson (BD) IVD Infectious Disease Product
Table 89. Becton Dickinson (BD) Revenue in IVD Infectious Disease Business (2016-2021) & (US$ Million)
Table 90. Becton Dickinson (BD) Recent Development
Table 91. Bio-Rad Laboratories Company Details
Table 92. Bio-Rad Laboratories Business Overview
Table 93. Bio-Rad Laboratories IVD Infectious Disease Product
Table 94. Bio-Rad Laboratories Revenue in IVD Infectious Disease Business (2016-2021) & (US$ Million)
Table 95. Bio-Rad Laboratories Recent Development
Table 96. Siemens Healthcare Company Details
Table 97. Siemens Healthcare Business Overview
Table 98. Siemens Healthcare IVD Infectious Disease Product
Table 99. Siemens Healthcare Revenue in IVD Infectious Disease Business (2016-2021) & (US$ Million)
Table 100. Siemens Healthcare Recent Development
Table 101. Biomérieux Company Details
Table 102. Biomérieux Business Overview
Table 103. Biomérieux Revenue in IVD Infectious Disease Business (2016-2021) & (US$ Million)
Table 104. Biomérieux Recent Development
Table 105. Danaher Company Details
Table 106. Danaher Business Overview
Table 107. Danaher IVD Infectious Disease Product
Table 108. Danaher Revenue in IVD Infectious Disease Business (2016-2021) & (US$ Million)
Table 109. Danaher Recent Development
Table 110. Thermo Fisher Company Details
Table 111. Thermo Fisher Business Overview
Table 112. Thermo Fisher IVD Infectious Disease Product
Table 113. Thermo Fisher Revenue in IVD Infectious Disease Business (2016-2021) & (US$ Million)
Table 114. Thermo Fisher Recent Development
Table 115. Sysmex Company Details
Table 116. Sysmex Business Overview
Table 117. Sysmex IVD Infectious Disease Product
Table 118. Sysmex Revenue in IVD Infectious Disease Business (2016-2021) & (US$ Million)
Table 119. Sysmex Recent Development
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Global IVD Infectious Disease Market Share by Type: 2020 VS 2027
Figure 2. Biochemical Diagnosis Features
Figure 3. Immune Diagnosis Features
Figure 4. Molecular Diagnosis Features
Figure 5. Microbiological Diagnosis Features
Figure 6. Urine Diagnosis Features
Figure 7. Coagulation Diagnosis Features
Figure 8. Other Features
Figure 9. Global IVD Infectious Disease Market Share by Application: 2020 VS 2027
Figure 10. Personal Case Studies
Figure 11. Commercial Case Studies
Figure 12. Academic Case Studies
Figure 13. Other Case Studies
Figure 14. IVD Infectious Disease Report Years Considered
Figure 15. Global IVD Infectious Disease Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 16. Global IVD Infectious Disease Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global IVD Infectious Disease Market Share by Regions: 2020 VS 2027
Figure 18. Global IVD Infectious Disease Market Share by Regions (2022-2027)
Figure 19. Global IVD Infectious Disease Market Share by Players in 2020
Figure 20. Global Top IVD Infectious Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in IVD Infectious Disease as of 2020
Figure 21. The Top 10 and 5 Players Market Share by IVD Infectious Disease Revenue in 2020
Figure 22. Global IVD Infectious Disease Revenue Market Share by Type (2016-2021)
Figure 23. Global IVD Infectious Disease Revenue Market Share by Type (2022-2027)
Figure 24. North America IVD Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. North America IVD Infectious Disease Market Share by Type (2016-2027)
Figure 26. North America IVD Infectious Disease Market Share by Application (2016-2027)
Figure 27. North America IVD Infectious Disease Market Share by Country (2016-2027)
Figure 28. United States IVD Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Canada IVD Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe IVD Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe IVD Infectious Disease Market Share by Type (2016-2027)
Figure 32. Europe IVD Infectious Disease Market Share by Application (2016-2027)
Figure 33. Europe IVD Infectious Disease Market Share by Country (2016-2027)
Figure 34. Germany IVD Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. France IVD Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. U.K. IVD Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Italy IVD Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Russia IVD Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Nordic IVD Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific IVD Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific IVD Infectious Disease Market Share by Type (2016-2027)
Figure 42. Asia-Pacific IVD Infectious Disease Market Share by Application (2016-2027)
Figure 43. Asia-Pacific IVD Infectious Disease Market Share by Region (2016-2027)
Figure 44. China IVD Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Japan IVD Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. South Korea IVD Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Southeast Asia IVD Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. India IVD Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Australia IVD Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America IVD Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America IVD Infectious Disease Market Share by Type (2016-2027)
Figure 52. Latin America IVD Infectious Disease Market Share by Application (2016-2027)
Figure 53. Latin America IVD Infectious Disease Market Share by Country (2016-2027)
Figure 54. Mexico IVD Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Brazil IVD Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa IVD Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa IVD Infectious Disease Market Share by Type (2016-2027)
Figure 58. Middle East & Africa IVD Infectious Disease Market Share by Application (2016-2027)
Figure 59. Middle East & Africa IVD Infectious Disease Market Share by Country (2016-2027)
Figure 60. Turkey IVD Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Saudi Arabia IVD Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. UAE IVD Infectious Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. Roche Diagnostics Revenue Growth Rate in IVD Infectious Disease Business (2016-2021)
Figure 64. Abbott Laboratories Revenue Growth Rate in IVD Infectious Disease Business (2016-2021)
Figure 65. Abbott Revenue Growth Rate in IVD Infectious Disease Business (2016-2021)
Figure 66. Gen-Probe Revenue Growth Rate in IVD Infectious Disease Business (2016-2021)
Figure 67. Becton Dickinson (BD) Revenue Growth Rate in IVD Infectious Disease Business (2016-2021)
Figure 68. Bio-Rad Laboratories Revenue Growth Rate in IVD Infectious Disease Business (2016-2021)
Figure 69. Siemens Healthcare Revenue Growth Rate in IVD Infectious Disease Business (2016-2021)
Figure 70. Biomérieux Revenue Growth Rate in IVD Infectious Disease Business (2016-2021)
Figure 71. Danaher Revenue Growth Rate in IVD Infectious Disease Business (2016-2021)
Figure 72. Thermo Fisher Revenue Growth Rate in IVD Infectious Disease Business (2016-2021)
Figure 73. Sysmex Revenue Growth Rate in IVD Infectious Disease Business (2016-2021)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed

---